F10ed205 Bc4d 4744 Bc2e Dfd5027680df 01
Potassium Citrate Tablet
Product Images NDC 42543-407
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Potassium Citrate (NDC 42543-407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Strides Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
F10ed205 Bc4d 4744 Bc2e Dfd5027680df 02
Each extended-release tablet contains 5 mEq (540 m) potassium citrate, USP. The tablets are uncoated, pale yellow, bi-convex, round-shaped, debossed with 'S406' on one side and plain on the other. The usual dosage and full prescribing information can be found in the package insert, which should be dispensed with the bottle by pharmacists. This medication should be kept in a tight container at 20°-25°C (68°-77°F), with excursions permitted between 15°-30°C (59°-86°F) in a controlled room. This product has been manufactured by Strides Pharma Science Ltd in India and distributed by Strides Pharma Inc in East Brunswick, NJ.*
F10ed205 Bc4d 4744 Bc2e Dfd5027680df 03
Each tablet contains 10mEq (1080mg) of potassium citrate with NDC number 42543-407-01. The tablet is pale yellow, uncoated, biconvex, caplet shaped with an imprint of 'S407' on one side and plain on the other. It is distributed by Strides Pharma Inc. The usual dosage should be referred to the package insert for full prescribing information. The tablets should be kept in a tight container at a temperature of 20°C to 25°C (68°F to 77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F). The pharmacist should dispense this drug in the original container without repackaging. The package insert should come with the bottle.*
F10ed205 Bc4d 4744 Bc2e Dfd5027680df 04
This is a prescription drug called Potassium Citrate Extended-Release Tablets, USP. Each tablet contains 15 mEq (1620 mg) of the drug, and is pale yellow and bi-convex in shape. The tablet is uncoated and has '5408' imprinted on one side. The recommended dosage can be found in the package insert, and it is important to keep this and all drugs out of the reach of children. It should be stored in a tight container at a temperature between 20-25°C, with excursions permitted between 15-30°C. The package is manufactured by Strides Pharma Science Ltd., Puducherry, India and distributed by Strides Pharma Inc., East Brunswick, NJ 08816.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
